Tsung‐Hsing Hung

814 total citations
57 papers, 630 citations indexed

About

Tsung‐Hsing Hung is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Tsung‐Hsing Hung has authored 57 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 42 papers in Hepatology and 19 papers in Surgery. Recurrent topics in Tsung‐Hsing Hung's work include Liver Disease Diagnosis and Treatment (40 papers), Liver Disease and Transplantation (34 papers) and Hepatitis B Virus Studies (9 papers). Tsung‐Hsing Hung is often cited by papers focused on Liver Disease Diagnosis and Treatment (40 papers), Liver Disease and Transplantation (34 papers) and Hepatitis B Virus Studies (9 papers). Tsung‐Hsing Hung collaborates with scholars based in Taiwan, United States and France. Tsung‐Hsing Hung's co-authors include Chih‐Chun Tsai, Chih‐Wei Tseng, Chen–Chi Tsai, Yu‐Hsi Hsieh, Kuo‐Chih Tseng, Chia-Chou Yeh, Tzung‐Yi Tsai, Hanoch Livneh, Ming‐Chi Lu and Deng‐Chyang Wu and has published in prestigious journals such as PLoS ONE, Annals of Oncology and International Journal of Environmental Research and Public Health.

In The Last Decade

Tsung‐Hsing Hung

56 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tsung‐Hsing Hung Taiwan 15 350 328 226 113 70 57 630
Louise China United Kingdom 13 515 1.5× 448 1.4× 249 1.1× 109 1.0× 52 0.7× 30 782
José Milicua Spain 10 430 1.2× 367 1.1× 272 1.2× 103 0.9× 39 0.6× 18 618
Matthew Bowles United Kingdom 14 520 1.5× 205 0.6× 555 2.5× 85 0.8× 66 0.9× 33 827
N. Terreni Italy 11 600 1.7× 519 1.6× 375 1.7× 103 0.9× 103 1.5× 19 938
Mireia Miquel Spain 15 594 1.7× 555 1.7× 283 1.3× 105 0.9× 20 0.3× 60 882
G Marenco Italy 9 356 1.0× 333 1.0× 299 1.3× 108 1.0× 65 0.9× 21 663
Albert Pardo Spain 9 473 1.4× 449 1.4× 411 1.8× 196 1.7× 71 1.0× 26 799
Ignacio Alfaro Spain 13 269 0.8× 428 1.3× 304 1.3× 33 0.3× 48 0.7× 27 818
Konstantinos C. Thomopoulos Greece 12 242 0.7× 290 0.9× 296 1.3× 94 0.8× 77 1.1× 25 730

Countries citing papers authored by Tsung‐Hsing Hung

Since Specialization
Citations

This map shows the geographic impact of Tsung‐Hsing Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsung‐Hsing Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsung‐Hsing Hung more than expected).

Fields of papers citing papers by Tsung‐Hsing Hung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsung‐Hsing Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsung‐Hsing Hung. The network helps show where Tsung‐Hsing Hung may publish in the future.

Co-authorship network of co-authors of Tsung‐Hsing Hung

This figure shows the co-authorship network connecting the top 25 collaborators of Tsung‐Hsing Hung. A scholar is included among the top collaborators of Tsung‐Hsing Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsung‐Hsing Hung. Tsung‐Hsing Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dziadziuszko, Rafał, Fabrice André, Wesley Yip, et al.. (2020). 1193P Clinical validity of FoundationOne liquid CDx (F1L CDx) assay as an aid in selecting patients for treatment with entrectinib. Annals of Oncology. 31. S785–S786. 4 indexed citations
2.
Hung, Tsung‐Hsing, et al.. (2019). Effect of proton pump inhibitors on mortality of cirrhotic patients with pneumonia. PLoS ONE. 14(4). e0216041–e0216041. 7 indexed citations
4.
Wu, Cheng‐Kun, Chih‐Ming Liang, Wei‐Chen Tai, et al.. (2018). Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan. International Journal of Environmental Research and Public Health. 15(12). 2655–2655. 13 indexed citations
5.
Chuah, Seng‐Kee, Shih‐Cheng Yang, Chih‐Ming Liang, et al.. (2018). Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis. PLoS ONE. 13(5). e0197127–e0197127. 15 indexed citations
6.
Tseng, Chih‐Wei, Tsung‐Hsing Hung, Chih‐Chun Tsai, et al.. (2018). The long-term outcomes of cirrhotic patients with pleural effusion. Saudi Journal of Gastroenterology. 24(1). 46–46. 29 indexed citations
7.
Wang, Jiunn‐Wei, Chien‐Ning Hsu, Chih‐Ming Liang, et al.. (2018). Association between Helicobacter pylori eradication and the risk of coronary heart diseases. PLoS ONE. 13(1). e0190219–e0190219. 29 indexed citations
8.
Hung, Tsung‐Hsing, Chih‐Wei Tseng, Chen–Chi Tsai, et al.. (2017). Mortality Following Catheter Drainage Versus Thoracentesis in Cirrhotic Patients with Pleural Effusion. Digestive Diseases and Sciences. 62(4). 1080–1085. 14 indexed citations
9.
Hung, Tsung‐Hsing, Chih‐Ming Liang, Chien‐Ning Hsu, et al.. (2017). Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan. PLoS ONE. 12(7). e0181858–e0181858. 29 indexed citations
10.
Hung, Tsung‐Hsing, et al.. (2016). The Effect of Renal Function Impairment on the Mortality of Cirrhotic Patients: A Nationwide Population-Based 3-Year Follow-up Study. PLoS ONE. 11(9). e0162987–e0162987. 6 indexed citations
11.
Tseng, Chih‐Wei, et al.. (2016). No mortality difference following treatment with terlipressin or somatostatin in cirrhotic patients with gastric variceal hemorrhage. Saudi Journal of Gastroenterology. 22(3). 220–220. 5 indexed citations
12.
Hung, Tsung‐Hsing, Chen–Chi Tsai, Kuo‐Chih Tseng, et al.. (2016). High Mortality of Cirrhotic Patients With End-Stage Renal Disease. Medicine. 95(10). e3057–e3057. 10 indexed citations
13.
Tseng, Kuo‐Chih, Chih‐Wei Tseng, Ting‐Tsung Chang, et al.. (2016). Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C. Clinical Interventions in Aging. 11. 327–327. 4 indexed citations
14.
Hung, Tsung‐Hsing, Yu‐Hsi Hsieh, Kuo‐Chih Tseng, et al.. (2015). High mortality in cirrhotic patients following hemorrhagic stroke. Journal of Clinical Neuroscience. 22(6). 995–997. 3 indexed citations
15.
Hung, Tsung‐Hsing, et al.. (2014). The Effect of Tuberculosis on the Mortality of Cirrhotic Patients. Medicine. 93(28). e295–e295. 2 indexed citations
16.
Hung, Tsung‐Hsing, et al.. (2014). Increased occurrence of native septic arthritis in adult cirrhotic patients: a population-based three-year follow-up study in Taiwan. Gastroenterology Review. 6(6). 342–347. 7 indexed citations
17.
Hsieh, Yu‐Hsi, Hwai‐Jeng Lin, Kuo‐Chih Tseng, et al.. (2013). Meperidine as the single sedative agent during esophagogastroduodenoscopy, a double‐blind, randomized, controlled study. Journal of Gastroenterology and Hepatology. 28(7). 1167–1173. 5 indexed citations
18.
Hung, Tsung‐Hsing, Chih‐Wei Tseng, Yu‐Hsi Hsieh, et al.. (2013). High mortality of pneumonia in cirrhotic patients with ascites. BMC Gastroenterology. 13(1). 25–25. 34 indexed citations
19.
Hung, Tsung‐Hsing, et al.. (2012). Is transarterial chemoembolization beneficial for patients with diffuse infiltrative hepatocellular carcinoma?. Hepatology International. 7(2). 676–682. 8 indexed citations
20.
Hung, Tsung‐Hsing, et al.. (2012). Effect of Renal Impairment on Mortality of Patients With Cirrhosis and Spontaneous Bacterial Peritonitis. Clinical Gastroenterology and Hepatology. 10(6). 677–681. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026